Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Low Back Pain | 19 | 2024 | 989 | 3.970 |
Why?
|
Fibromyalgia | 17 | 2023 | 407 | 3.760 |
Why?
|
Receptors, GABA | 25 | 2024 | 312 | 3.170 |
Why?
|
Positron-Emission Tomography | 36 | 2024 | 6550 | 2.010 |
Why?
|
Brain | 47 | 2024 | 27163 | 1.690 |
Why?
|
Pain | 21 | 2023 | 5101 | 1.650 |
Why?
|
Neuroglia | 9 | 2020 | 960 | 1.610 |
Why?
|
Acetamides | 7 | 2024 | 259 | 1.270 |
Why?
|
Hyperalgesia | 4 | 2015 | 527 | 1.260 |
Why?
|
Pain Threshold | 10 | 2022 | 607 | 1.180 |
Why?
|
Osteoarthritis, Knee | 4 | 2023 | 1251 | 1.180 |
Why?
|
Punishment | 3 | 2020 | 95 | 1.010 |
Why?
|
Pain Measurement | 15 | 2023 | 3584 | 0.970 |
Why?
|
Pain Perception | 5 | 2017 | 198 | 0.960 |
Why?
|
Spin Labels | 6 | 2022 | 334 | 0.910 |
Why?
|
Neuralgia | 4 | 2024 | 619 | 0.910 |
Why?
|
Persian Gulf Syndrome | 2 | 2021 | 48 | 0.850 |
Why?
|
Brain Mapping | 15 | 2021 | 6597 | 0.760 |
Why?
|
Pyridines | 9 | 2024 | 2890 | 0.750 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2022 | 1389 | 0.740 |
Why?
|
Magnetic Resonance Imaging | 53 | 2024 | 36582 | 0.720 |
Why?
|
Catastrophization | 8 | 2022 | 352 | 0.670 |
Why?
|
Reward | 3 | 2020 | 980 | 0.650 |
Why?
|
Autonomic Nervous System | 3 | 2019 | 707 | 0.640 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.620 |
Why?
|
Carbon Radioisotopes | 7 | 2024 | 544 | 0.590 |
Why?
|
Anticipation, Psychological | 1 | 2018 | 90 | 0.580 |
Why?
|
Prefrontal Cortex | 5 | 2020 | 2224 | 0.530 |
Why?
|
Hot Temperature | 3 | 2012 | 1441 | 0.530 |
Why?
|
Rheumatic Diseases | 1 | 2023 | 659 | 0.520 |
Why?
|
Pyrimidines | 9 | 2024 | 3044 | 0.510 |
Why?
|
Amyotrophic Lateral Sclerosis | 7 | 2022 | 1481 | 0.510 |
Why?
|
Brain Diseases | 2 | 2022 | 1551 | 0.500 |
Why?
|
Cerebrovascular Circulation | 4 | 2022 | 2672 | 0.490 |
Why?
|
Neural Pathways | 12 | 2019 | 3078 | 0.470 |
Why?
|
Corpus Striatum | 1 | 2020 | 1217 | 0.440 |
Why?
|
Arthritis, Rheumatoid | 2 | 2019 | 3778 | 0.420 |
Why?
|
Adult | 63 | 2024 | 223317 | 0.400 |
Why?
|
Cerebral Cortex | 8 | 2024 | 5754 | 0.390 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2016 | 240 | 0.390 |
Why?
|
Somatosensory Cortex | 4 | 2024 | 506 | 0.390 |
Why?
|
Choline | 3 | 2023 | 511 | 0.390 |
Why?
|
Image Processing, Computer-Assisted | 12 | 2024 | 8940 | 0.390 |
Why?
|
Inflammation | 10 | 2024 | 10869 | 0.380 |
Why?
|
Creatine | 3 | 2023 | 424 | 0.380 |
Why?
|
Humans | 107 | 2024 | 767040 | 0.380 |
Why?
|
Meninges | 2 | 2024 | 197 | 0.360 |
Why?
|
Psychophysics | 5 | 2015 | 292 | 0.350 |
Why?
|
Aspartic Acid | 2 | 2023 | 575 | 0.340 |
Why?
|
Manipulation, Spinal | 2 | 2020 | 21 | 0.340 |
Why?
|
Dexmedetomidine | 4 | 2018 | 321 | 0.330 |
Why?
|
Catechol O-Methyltransferase | 1 | 2011 | 251 | 0.330 |
Why?
|
Thalamus | 3 | 2023 | 1040 | 0.330 |
Why?
|
Neuronal Plasticity | 4 | 2020 | 1446 | 0.330 |
Why?
|
Motor Cortex | 3 | 2024 | 1005 | 0.320 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 1 | 2009 | 41 | 0.320 |
Why?
|
Frontal Lobe | 3 | 2022 | 1408 | 0.310 |
Why?
|
Middle Aged | 50 | 2024 | 223233 | 0.310 |
Why?
|
Galvanic Skin Response | 1 | 2011 | 359 | 0.310 |
Why?
|
Central Nervous System | 1 | 2016 | 1345 | 0.310 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2023 | 3684 | 0.310 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 3 | 2024 | 253 | 0.300 |
Why?
|
Male | 63 | 2024 | 364203 | 0.290 |
Why?
|
Neuroimmunomodulation | 2 | 2020 | 186 | 0.280 |
Why?
|
Migraine with Aura | 2 | 2020 | 203 | 0.280 |
Why?
|
Amino Acid Substitution | 1 | 2011 | 1743 | 0.280 |
Why?
|
Neurons, Afferent | 2 | 2019 | 498 | 0.270 |
Why?
|
Pruritus | 3 | 2015 | 378 | 0.270 |
Why?
|
Female | 63 | 2024 | 396660 | 0.270 |
Why?
|
Empathy | 2 | 2008 | 474 | 0.260 |
Why?
|
Multiple Sclerosis | 5 | 2024 | 3229 | 0.260 |
Why?
|
Nerve Net | 4 | 2020 | 2307 | 0.260 |
Why?
|
Veterans | 1 | 2020 | 2666 | 0.260 |
Why?
|
Dental Care | 1 | 2008 | 285 | 0.250 |
Why?
|
Pandemics | 2 | 2023 | 8736 | 0.250 |
Why?
|
Physical Stimulation | 2 | 2020 | 514 | 0.240 |
Why?
|
Models, Neurological | 1 | 2012 | 1747 | 0.230 |
Why?
|
Up-Regulation | 2 | 2024 | 4143 | 0.220 |
Why?
|
Stroke | 2 | 2023 | 9746 | 0.220 |
Why?
|
Attitude | 1 | 2008 | 769 | 0.220 |
Why?
|
Case-Control Studies | 8 | 2021 | 22254 | 0.210 |
Why?
|
Video Recording | 1 | 2008 | 977 | 0.210 |
Why?
|
Astrocytes | 3 | 2020 | 1352 | 0.210 |
Why?
|
Knee Joint | 2 | 2023 | 1683 | 0.200 |
Why?
|
Acupuncture Therapy | 2 | 2020 | 485 | 0.200 |
Why?
|
Depression | 2 | 2020 | 8234 | 0.200 |
Why?
|
Kinetics | 2 | 2021 | 6287 | 0.190 |
Why?
|
Attention | 3 | 2010 | 2413 | 0.190 |
Why?
|
Minocycline | 1 | 2023 | 170 | 0.190 |
Why?
|
Microglia | 3 | 2019 | 1370 | 0.190 |
Why?
|
Cognition Disorders | 1 | 2015 | 3968 | 0.180 |
Why?
|
Pressure | 3 | 2020 | 1172 | 0.180 |
Why?
|
Cannabidiol | 1 | 2022 | 123 | 0.180 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 2 | 2018 | 92 | 0.170 |
Why?
|
Pyridostigmine Bromide | 1 | 2020 | 32 | 0.170 |
Why?
|
Gulf War | 1 | 2020 | 33 | 0.170 |
Why?
|
Agnosia | 1 | 2020 | 67 | 0.170 |
Why?
|
Hypercapnia | 1 | 2021 | 259 | 0.170 |
Why?
|
Cerebellum | 2 | 2019 | 1521 | 0.170 |
Why?
|
Emotions | 2 | 2008 | 2760 | 0.160 |
Why?
|
Gliosis | 1 | 2020 | 246 | 0.160 |
Why?
|
Heart Rate | 1 | 2011 | 4209 | 0.160 |
Why?
|
Long QT Syndrome | 1 | 2023 | 473 | 0.160 |
Why?
|
Touch Perception | 1 | 2020 | 106 | 0.160 |
Why?
|
Primates | 1 | 2021 | 519 | 0.150 |
Why?
|
Histone Deacetylases | 2 | 2024 | 712 | 0.150 |
Why?
|
Aromatase Inhibitors | 1 | 2022 | 519 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2020 | 443 | 0.150 |
Why?
|
Young Adult | 20 | 2024 | 59980 | 0.150 |
Why?
|
Peripheral Nervous System | 1 | 2019 | 151 | 0.150 |
Why?
|
Receptors, Opioid | 1 | 2018 | 145 | 0.150 |
Why?
|
Spinal Nerve Roots | 1 | 2018 | 122 | 0.150 |
Why?
|
Delirium | 2 | 2020 | 1698 | 0.140 |
Why?
|
Motor Neuron Disease | 1 | 2017 | 98 | 0.140 |
Why?
|
Fluorine Radioisotopes | 1 | 2020 | 405 | 0.140 |
Why?
|
Aged | 20 | 2024 | 171319 | 0.140 |
Why?
|
Unconsciousness | 2 | 2017 | 251 | 0.130 |
Why?
|
Perfusion | 1 | 2021 | 1409 | 0.130 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 2 | 2024 | 551 | 0.130 |
Why?
|
Rats, Sprague-Dawley | 2 | 2024 | 8108 | 0.130 |
Why?
|
Motor Neurons | 2 | 2022 | 869 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 16036 | 0.130 |
Why?
|
Radiculopathy | 1 | 2018 | 203 | 0.130 |
Why?
|
Habituation, Psychophysiologic | 1 | 2016 | 144 | 0.130 |
Why?
|
Vascular Diseases | 1 | 2024 | 1161 | 0.130 |
Why?
|
Diffusion Tensor Imaging | 4 | 2020 | 2421 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2022 | 856 | 0.120 |
Why?
|
Primary Dysautonomias | 1 | 2015 | 28 | 0.120 |
Why?
|
Fatigue | 1 | 2022 | 1556 | 0.120 |
Why?
|
Encephalitis | 1 | 2019 | 441 | 0.120 |
Why?
|
Locus Coeruleus | 1 | 2017 | 241 | 0.120 |
Why?
|
Back Pain | 1 | 2019 | 547 | 0.120 |
Why?
|
Limbic System | 1 | 2017 | 418 | 0.120 |
Why?
|
Spinal Cord | 2 | 2022 | 1811 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1168 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1011 | 0.110 |
Why?
|
Dermatitis, Atopic | 3 | 2015 | 734 | 0.110 |
Why?
|
Headache Disorders | 1 | 2015 | 152 | 0.100 |
Why?
|
Rest | 4 | 2022 | 941 | 0.100 |
Why?
|
Anti-Retroviral Agents | 1 | 2022 | 1787 | 0.100 |
Why?
|
Oxygen | 5 | 2015 | 4252 | 0.100 |
Why?
|
Hypnotics and Sedatives | 2 | 2017 | 1193 | 0.100 |
Why?
|
Adipose Tissue, Brown | 1 | 2018 | 776 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2024 | 4925 | 0.100 |
Why?
|
Gyrus Cinguli | 1 | 2018 | 1118 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2114 | 0.100 |
Why?
|
Psychomotor Performance | 1 | 2020 | 1886 | 0.100 |
Why?
|
Arousal | 1 | 2017 | 1174 | 0.090 |
Why?
|
Huntington Disease | 1 | 2018 | 1147 | 0.090 |
Why?
|
Brain Stem | 1 | 2016 | 858 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2023 | 12451 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 18063 | 0.090 |
Why?
|
Statistics as Topic | 2 | 2015 | 2350 | 0.090 |
Why?
|
Epigenesis, Genetic | 1 | 2024 | 3828 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2023 | 3001 | 0.090 |
Why?
|
Rats | 3 | 2024 | 23713 | 0.080 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 490 | 0.080 |
Why?
|
Pyrazoles | 1 | 2020 | 2028 | 0.080 |
Why?
|
Fear | 1 | 2018 | 1496 | 0.080 |
Why?
|
Temporal Lobe | 1 | 2017 | 1717 | 0.080 |
Why?
|
Quebec | 1 | 2009 | 140 | 0.080 |
Why?
|
Dental Anxiety | 1 | 2008 | 8 | 0.080 |
Why?
|
Cohort Studies | 4 | 2021 | 41718 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2018 | 2702 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2270 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10393 | 0.080 |
Why?
|
Endorphins | 1 | 2008 | 73 | 0.080 |
Why?
|
Stress, Psychological | 2 | 2017 | 4526 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 2188 | 0.080 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2009 | 303 | 0.070 |
Why?
|
Genotype | 2 | 2015 | 13035 | 0.070 |
Why?
|
Facial Pain | 1 | 2008 | 119 | 0.070 |
Why?
|
Reaction Time | 2 | 2011 | 2086 | 0.070 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3837 | 0.070 |
Why?
|
Sensation | 1 | 2008 | 331 | 0.070 |
Why?
|
Narcotics | 1 | 2008 | 332 | 0.070 |
Why?
|
Affect | 1 | 2014 | 1494 | 0.070 |
Why?
|
Genes, Recessive | 1 | 2009 | 624 | 0.070 |
Why?
|
Linear Models | 2 | 2015 | 5875 | 0.070 |
Why?
|
Amygdala | 1 | 2014 | 1375 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6215 | 0.060 |
Why?
|
Syndrome | 2 | 2022 | 3271 | 0.060 |
Why?
|
Analgesia | 1 | 2010 | 461 | 0.060 |
Why?
|
Adolescent | 11 | 2020 | 89046 | 0.060 |
Why?
|
Animals | 7 | 2024 | 168965 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3227 | 0.060 |
Why?
|
Aging | 1 | 2023 | 8729 | 0.060 |
Why?
|
Nociceptors | 1 | 2008 | 460 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2023 | 65295 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2018 | 3797 | 0.060 |
Why?
|
Neurotransmitter Agents | 1 | 2008 | 661 | 0.060 |
Why?
|
Placebo Effect | 1 | 2008 | 516 | 0.060 |
Why?
|
Mutation | 1 | 2009 | 30211 | 0.060 |
Why?
|
Behavior Therapy | 1 | 2010 | 886 | 0.060 |
Why?
|
Awareness | 1 | 2008 | 653 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2016 | 1712 | 0.050 |
Why?
|
Hand | 1 | 2008 | 910 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 26325 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3683 | 0.050 |
Why?
|
Spinal Nerves | 1 | 2022 | 92 | 0.050 |
Why?
|
Phenotype | 2 | 2024 | 16718 | 0.050 |
Why?
|
Gene Frequency | 1 | 2009 | 3621 | 0.050 |
Why?
|
Perception | 1 | 2008 | 1205 | 0.050 |
Why?
|
Brain Infarction | 1 | 2023 | 285 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1312 | 0.050 |
Why?
|
Neurons | 1 | 2020 | 9517 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18330 | 0.050 |
Why?
|
Photic Stimulation | 1 | 2007 | 1989 | 0.050 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2022 | 329 | 0.050 |
Why?
|
Cross-Over Studies | 2 | 2020 | 2105 | 0.050 |
Why?
|
Sciatic Nerve | 1 | 2024 | 627 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4114 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 2024 | 624 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20169 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2022 | 529 | 0.040 |
Why?
|
Schizophrenia | 1 | 2018 | 6977 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2022 | 638 | 0.040 |
Why?
|
Inositol | 1 | 2020 | 216 | 0.040 |
Why?
|
Rodentia | 1 | 2020 | 262 | 0.040 |
Why?
|
Advisory Committees | 1 | 2023 | 797 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2020 | 377 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2887 | 0.040 |
Why?
|
Arthralgia | 1 | 2022 | 459 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 786 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2020 | 376 | 0.040 |
Why?
|
Sensory Receptor Cells | 1 | 2022 | 509 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2020 | 382 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9464 | 0.040 |
Why?
|
Thalamic Nuclei | 1 | 2018 | 110 | 0.040 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 258 | 0.040 |
Why?
|
Atrophy | 1 | 2022 | 1631 | 0.040 |
Why?
|
Putamen | 1 | 2018 | 288 | 0.030 |
Why?
|
Down-Regulation | 1 | 2024 | 2931 | 0.030 |
Why?
|
Globus Pallidus | 1 | 2018 | 247 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20741 | 0.030 |
Why?
|
Saliva | 1 | 2021 | 853 | 0.030 |
Why?
|
Sodium Chloride | 1 | 2018 | 580 | 0.030 |
Why?
|
Anisotropy | 1 | 2020 | 1289 | 0.030 |
Why?
|
Cortical Spreading Depression | 1 | 2020 | 288 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2020 | 1587 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4401 | 0.030 |
Why?
|
Genetic Testing | 1 | 2009 | 3591 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1154 | 0.030 |
Why?
|
Skull | 1 | 2020 | 819 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2021 | 1182 | 0.030 |
Why?
|
HIV Infections | 1 | 2022 | 17542 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21178 | 0.030 |
Why?
|
Trigeminal Nerve | 1 | 2016 | 248 | 0.030 |
Why?
|
Anxiety | 1 | 2010 | 4670 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2023 | 81659 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2018 | 15925 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 640 | 0.030 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2024 | 1498 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2227 | 0.030 |
Why?
|
Electrophysiological Phenomena | 1 | 2015 | 309 | 0.030 |
Why?
|
Skin Tests | 1 | 2015 | 630 | 0.030 |
Why?
|
Antipruritics | 1 | 2012 | 31 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1142 | 0.030 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.030 |
Why?
|
Cardiopulmonary Bypass | 1 | 2018 | 1097 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1768 | 0.020 |
Why?
|
Hypnosis | 1 | 2012 | 83 | 0.020 |
Why?
|
Neurofeedback | 1 | 2012 | 50 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14098 | 0.020 |
Why?
|
Quality of Life | 2 | 2022 | 13485 | 0.020 |
Why?
|
Sensory System Agents | 1 | 2010 | 24 | 0.020 |
Why?
|
Exercise Therapy | 1 | 2017 | 939 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 950 | 0.020 |
Why?
|
Consciousness | 1 | 2014 | 602 | 0.020 |
Why?
|
Capsaicin | 1 | 2010 | 233 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5311 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9360 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 533 | 0.020 |
Why?
|
Chronic Disease | 2 | 2014 | 9362 | 0.020 |
Why?
|
Mood Disorders | 1 | 2014 | 1129 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1233 | 0.020 |
Why?
|
Allergens | 1 | 2015 | 1436 | 0.020 |
Why?
|
Self-Assessment | 1 | 2010 | 400 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 6210 | 0.020 |
Why?
|
Forearm | 1 | 2009 | 427 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1829 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2811 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8732 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2014 | 6023 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39317 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8048 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14766 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6331 | 0.010 |
Why?
|
Psychotic Disorders | 1 | 2018 | 3275 | 0.010 |
Why?
|
Functional Laterality | 1 | 2009 | 2245 | 0.010 |
Why?
|
Sleep | 1 | 2018 | 4816 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3370 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6409 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13646 | 0.010 |
Why?
|
Cognition | 1 | 2018 | 7059 | 0.010 |
Why?
|
Electroencephalography | 1 | 2014 | 6282 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4968 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7121 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10622 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40154 | 0.000 |
Why?
|